SkyAI, Inc. SEC Filings

Jason L. Monroe, a director of Sharps Technology Inc. (STSS), was granted an option to purchase 80,000 shares on 08/22/2025 with an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and will become 100% vested and exercisable on May 22, 2026. The Form 4 was signed by Mr. Monroe on 08/26/2025.

Andrew R. Crescenzo, who serves as Chief Financial Officer and a director of Sharps Technology Inc., was granted an option to purchase 40,000 shares on 08/22/2025 at an exercise price of $6.41 per share under the company's 2025 Equity Incentive Plan. The option is shown as directly beneficially owned for 40,000 shares following the grant and will become 100% vested and exercisable on May 22, 2026. The Form 4 was signed by Mr. Crescenzo on 08/26/2025. The filing lists the issuer as Sharps Technology Inc. (STSS).

Robert M. Hayes, a director of Sharps Technology Inc. (ticker shown as STSS), reported a securities transaction on a Form 4. The filing records an option (right to buy) for 100,000 shares with a price of $6.41. The transaction line shows the option entry dated 08/22/2025 and indicates the shares were acquired (code A) and are held directly. The filing notes the grant was made under the Company’s 2025 Equity Incentive Plan and that the option will be 100% vested as of the issuance date. The form includes an earliest-transaction date of 12/04/2024 and a signature dated 08/26/2025.

The reporting person, Soren Bo Christiansen, a director of Sharps Technology Inc. (STSS), was granted an option to purchase 80,000 shares on 08/22/2025 at an exercise price of $6.41 per share under the company's 2025 Equity Incentive Plan. The option will become 100% vested and exercisable on May 22, 2026. Following the grant the reporting person beneficially owns 80,000 shares/options as reported.

Brenda Baird Simpson, a director of Sharps Technology Inc. (ticker: STSSW), was granted a non‑derivative option to purchase 20,000 shares on 08/22/2025 at an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and "will become 100% vested as of the date of issuance," per the filing. Following the grant, Ms. Simpson directly beneficially owns 20,000 shares/options reported on this Form 4.

Paul K. Danner, a director of Sharps Technology Inc. (STSS), was granted options to purchase 400,000 shares at an exercise price of $6.41 per share. The grant was reported with a transaction date of 08/22/2025 and the option is scheduled to become 100% vested and exercisable on May 22, 2026. Following the reported transaction, Mr. Danner beneficially owns 400,000 shares subject to the option on a direct basis. The grant was made pursuant to the company's 2025 Equity Incentive Plan.

Sharps Technology, Inc. entered into cash and cryptocurrency private placement agreements to sell common stock, pre-funded warrants and stapled warrants, targeting estimated aggregate gross proceeds of about $400 million before fees to implement a Solana-focused treasury strategy. Cash investors will pay in U.S. dollars or stablecoins, while cryptocurrency investors will pay in SOL tokens, with related warrants generally exercisable at $0.0001 for pre-funded shares and $9.75 for stapled warrants, subject in part to stockholder approval.

The company plans to use proceeds to buy SOL via open-market purchases, build Solana treasury operations, and for general corporate purposes, held in a separate account. Authorized common shares were increased from 1,666,667 to 500,000,000, significantly expanding potential issuance capacity. Existing Series A warrants for 347,774 shares had their exercise price cut from $87.60 to $6.50.

Leadership changed as CEO and director Robert M. Hayes resigned, receiving a $1.2 million lump-sum payment, extended benefits and fully vested options for 100,000 shares. Paul K. Danner became Executive Chairman and Principal Executive Officer with a $600,000 annual salary, and Yuwen (Alice) Zhang was appointed Chief Investment Officer and director, also with a $600,000 base salary. The company signed a settlement term sheet over prior litigation that could materially affect its financial position if the offering is not completed, and a non-binding LOI under which the Solana Foundation may sell $50 million of SOL to the company at a 15% discount following a public offering.

Sharps Technology, Inc. is registering 2,000,000 common shares on Form S-8 for issuance under its 2025 Equity Incentive Plan.

The plan is designed to provide compensation, enticement, and incentive awards, allowing the company to grant equity-based awards to eligible participants. The filing also outlines Nevada law and corporate provisions that allow the company to indemnify its directors, officers, employees, and agents in certain circumstances, and notes that Sharps maintains directors’ and officers’ liability insurance. Standard undertakings confirm that future SEC reports will update this registration by reference.

Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP and Altium Healthcare Long Short GP LLC jointly report beneficial ownership of 35,659 shares of Sharps Technology Inc. common stock issuable upon conversion of Series A warrants, representing 3.48% of the class based on 1,023,214 shares outstanding.

The filing notes the Series A warrants are subject to a 9.99% Warrant Blocker that prevents exercise to the extent it would raise ownership above that threshold. The cover-page figures include the full number of shares issuable on conversion and do not give effect to the Warrant Blocker, so the actual number of shares the reporting persons could beneficially own after giving effect to the blocker is less than the reported amount. Reported sole voting and dispositive power are 0, with 35,659 shared voting and dispositive power.